Clopidogrel plus aspirin vs aspirin alone for preventing cardiovascular disease in high risk persons not presenting acutely
Clopidogrel plus aspirin vs aspirin alone for preventing cardiovascular disease in high risk persons not presenting acutely is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Clopidogrel Plus Aspirin Vs Aspirin Alone for Preventing Cardiovascular Disease in High Risk Persons Not Presenting Acutely." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450488/all/Clopidogrel_plus_aspirin_vs_aspirin_alone_for_preventing_cardiovascular_disease_in_high_risk_persons_not_presenting_acutely.
Clopidogrel plus aspirin vs aspirin alone for preventing cardiovascular disease in high risk persons not presenting acutely. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450488/all/Clopidogrel_plus_aspirin_vs_aspirin_alone_for_preventing_cardiovascular_disease_in_high_risk_persons_not_presenting_acutely. Accessed January 25, 2021.
Clopidogrel plus aspirin vs aspirin alone for preventing cardiovascular disease in high risk persons not presenting acutely. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. Retrieved January 25, 2021, from https://evidence.unboundmedicine.com/evidence/view/EBMG/450488/all/Clopidogrel_plus_aspirin_vs_aspirin_alone_for_preventing_cardiovascular_disease_in_high_risk_persons_not_presenting_acutely
Clopidogrel Plus Aspirin Vs Aspirin Alone for Preventing Cardiovascular Disease in High Risk Persons Not Presenting Acutely [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2021 January 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450488/all/Clopidogrel_plus_aspirin_vs_aspirin_alone_for_preventing_cardiovascular_disease_in_high_risk_persons_not_presenting_acutely.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Clopidogrel plus aspirin vs aspirin alone for preventing cardiovascular disease in high risk persons not presenting acutely
ID - 450488
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450488/all/Clopidogrel_plus_aspirin_vs_aspirin_alone_for_preventing_cardiovascular_disease_in_high_risk_persons_not_presenting_acutely
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -